The Alzheimer Center Amsterdam is supported by Stichting Alzheimer Nederland and Stichting VUmc fonds . The clinical database structure was developed with funding from Stichting Dioraphte . Research of the Alzheimer Center Amsterdam is part of the neurodegeneration research program of Amsterdam Neuroscience. W.F. is recipient of a donation by stichting Equilibrio, and of a ZonMW Memorabel grant (#733050814). F.L., A.D., M.K., and J.F. are appointed at the NUDAD project, which is funded by NWO-FCB (project number 057-14-004). W.F. holds the Pasman chair.
The authors would like to thank Eva Anne Hartman for her help with the administration and cleaning of the nutritional supplement data. F.L., O.R., A.D., J.F., M.S., M.V. and M.K. report no disclosures. E.H. is an employee of FrieslandCampina, P.S. has received consultancy/speaker fees (paid to the institution) from Novartis, Vivoryon, Genentech and EIP Pharma. C.T. has a collaboration contract with ADx Neurosciences, performed contract research or received grants from Probiodrug, Biogen, Esai, Toyama, Janssen prevention center, Boehringer, AxonNeurosciences, Fujirebio, EIP farma, PeopleBio, and Roche. Research programs of W.F. have been funded by ZonMW, NWO, EU-FP7, EU-JPND, Alzheimer Nederland, CardioVascular Onderzoek Nederland, Health~Holland, Topsector Life Sciences & Health, stichting Dioraphte, Gieskes-Strijbis fonds, stichting Equilibrio, Pasman stichting, Biogen MA Inc, Boehringer Ingelheim, Life-MI, AVID, Roche BV, Janssen Stellar, Combinostics. W.F. has performed contract research for Biogen MA Inc and Boehringer Ingelheim. W.F. has been an invited speaker at Boehringer Ingelheim and Biogen MA Inc. All funding is paid to her institution.